Course and predictors of work productivity in gout-results from the NOR-Gout longitudinal 2-year treat-to-target study.
Till UhligLars F KaroliussenJoe SextonSella Aarrestad ProvanTore K KvienEspen A HaavardsholmHilde Berner HammerPublished in: Rheumatology (Oxford, England) (2023)
In patients with gout who were intensively treated to the sUA target, work productivity and activity impairment were largely unchanged and at 1 year predicted by comorbidities and patient concerns about medication.